Comparison of 6-<sup>18</sup>F-Fluorodopamine PET with <sup>123</sup>I-Metaiodobenzylguanidine and <sup>111</sup>In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma - Concepedia

Concepedia

Publication | Open Access

Comparison of 6-<sup>18</sup>F-Fluorodopamine PET with <sup>123</sup>I-Metaiodobenzylguanidine and <sup>111</sup>In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma

DOI Full Paper Access

145

Citations

43

References

2008

Year

Ιoannis Ilias, Clara C. Chen, Jorge A. Carrasquillo, Millie Whatley, Alexander Ling, Ivica Lazúrová, Karen T. Adams, Shiromi M. Perera, Karel Pacák

Journal of Nuclear Medicine

Abstract

If available, (18)F-DA PET should be used in the evaluation of PHEO, because it is more sensitive than (123)I-MIBG scintigraphy or SRS. If (18)F-DA PET is not available, (123)I-MIBG scintigraphy (for nonmetastatic or adrenal PHEO) and SRS (for metastatic PHEO) should be the first alternative imaging methods to be used.

References

	Year	Citations

Page 1